SCHEMBL21767124

SCHEMBL21767124

COc1cccc(OC)c1-n1c(NSCCc2ccc(F)cc2C#N)nnc1-c1cccc(=O)[nH]1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18246320 0.85 APLNR (1.00) APLNR
SCHEMBL20200592 0.83 APLNR (0.73) APLNR
SCHEMBL20200969 0.83 APLNR (0.59) APLNR
SCHEMBL20207435 0.81 APLNR (0.73) APLNR
SCHEMBL22810455 0.80 APLNR (0.65) APLNR
SCHEMBL20200320 0.80 APLNR (0.74) APLNR
SCHEMBL22537248 0.79 APLNR (0.74) APLNR
SCHEMBL22537235 0.79 APLNR (0.74) APLNR
SCHEMBL19574006 0.79 APLNR (0.76) APLNR
SCHEMBL19573971 0.78 APLNR (0.50) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3300500-B9 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2021-01-13 EP disclosed
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP disclosed